|Eosinophil's role remains uncertain as anti–interleukin-5 only partially depletes numbers in asthmatic airway|
PT Flood-Page, AN Menzies-Gow, AB Kay, DS Robinson
American journal of respiratory and critical care medicine 167 (2), 199-204, 2003
|Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics|
P Flood-Page, A Menzies-Gow, S Phipps, S Ying, A Wangoo, MS Ludwig, ...
The Journal of clinical investigation 112 (7), 1029-1036, 2003
|Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics|
A Menzies-Gow, P Flood-Page, R Sehmi, J Burman, Q Hamid, ...
Journal of Allergy and Clinical Immunology 111 (4), 714-719, 2003
|Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early-and late-phase allergic reactions …|
A Menzies-Gow, S Ying, I Sabroe, VL Stubbs, D Soler, TJ Williams, ...
The Journal of Immunology 169 (5), 2712-2718, 2002
|Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult …|
J Sweeney, CC Patterson, A Menzies-Gow, RM Niven, AH Mansur, ...
Thorax 71 (4), 339-346, 2016
|Integrated care pathways for airway diseases (AIRWAYS-ICPs)|
J Bousquet, A Addis, I Adcock, I Agache, A Agusti, A Alonso, ...
European Respiratory Journal 44 (2), 304-323, 2014
|U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics|
D Lefaudeux, B De Meulder, MJ Loza, N Peffer, A Rowe, F Baribaud, ...
Journal of Allergy and Clinical Immunology 139 (6), 1797-1807, 2017
|The biology of eosinophils and their role in asthma|
CN McBrien, A Menzies-Gow
Frontiers in medicine 4, 93, 2017
|Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry|
LG Heaney, CE Brightling, A Menzies-Gow, M Stevenson, RM Niven, ...
Thorax 65 (9), 787-794, 2010
|Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies|
JM FitzGerald, ER Bleecker, A Menzies-Gow, JG Zangrilli, I Hirsch, ...
The Lancet Respiratory Medicine 6 (1), 51-64, 2018
|The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry|
S O'Neill, J Sweeney, CC Patterson, A Menzies-Gow, R Niven, ...
Thorax 70 (4), 376-378, 2015
|Co‐morbidities in severe asthma: C linical impact and management|
C Porsbjerg, A Menzies‐Gow
Respirology 22 (4), 651-661, 2017
|Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma|
NC Thomson, R Chaudhuri, LG Heaney, C Bucknall, RM Niven, ...
Journal of allergy and clinical immunology 131 (4), 1008-1016, 2013
|Phenotypic differences between pediatric and adult asthma|
A Bush, A Menzies-Gow
Proceedings of the American Thoracic Society 6 (8), 712-719, 2009
|Obesity-associated severe asthma represents a distinct clinical phenotype: analysis of the British Thoracic Society Difficult Asthma Registry Patient cohort according to BMI|
D Gibeon, K Batuwita, M Osmond, LG Heaney, CE Brightling, R Niven, ...
Chest 143 (2), 406-414, 2013
|Effectiveness of omalizumab in severe allergic asthma: a retrospective UK real-world study|
N Barnes, A Menzies-Gow, AH Mansur, D Spencer, F Percival, A Radwan, ...
Journal of Asthma 50 (5), 529-536, 2013
|Statistical cluster analysis of the British Thoracic Society Severe refractory Asthma Registry: clinical outcomes and phenotype stability|
C Newby, LG Heaney, A Menzies-Gow, RM Niven, A Mansur, C Bucknall, ...
PloS one 9 (7), e102987, 2014
|Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge|
YE Ong, A Menzies-Gow, J Barkans, F Benyahia, TT Ou, S Ying, AB Kay
Journal of allergy and clinical immunology 116 (3), 558-564, 2005
|Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma|
ER Bleecker, ME Wechsler, JM FitzGerald, A Menzies-Gow, Y Wu, ...
European Respiratory Journal 52 (4), 2018
|Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin|
S Phipps, P Flood-Page, A Menzies-Gow, YE Ong, AB Kay
Journal of investigative dermatology 122 (6), 1406-1412, 2004